Considering treatment in Lecheng?
Get clear answers first, then decide with confidence.
Lecheng is China's dedicated medical pilot zone, where a range of international innovative medicines, devices and advanced programmes are available under special licence. We focus on Lecheng only, in two areas: oncology and type 2 diabetes management. The first conversation is free. Nothing starts until the scope and fees are confirmed in writing — and every medical decision rests with the hospital and its doctors.
Available in Chinese and English.
China's medical pilot zone
Innovative medicines, devices and programmes arrive here earlier under special licensing. Before you travel, we answer three questions: Can you go? Which hospital is right? How does the process work?
- You don't need everything ready to talk to us — no passport scans, no payment details, no full medical file. Just tell us what you'd like to arrange.
- Two separate costs, from day one: our coordination fee, and the hospital's medical fees — quoted and charged by the hospital itself.
- If something isn't confirmed, we say so. We don't guess prices, promise outcomes, or guarantee that a hospital will accept your case.
Which of these sounds like you?
You don't need to know which programme you want yet. Choose the starting point closest to your situation, and we'll work through the rest together, step by step.
Why Lecheng: four things that set it apart
The Lecheng Pilot Zone is China's only medical pilot zone of its kind. Its special licences make it a primary gateway for innovative medicines and devices entering China, with a care pathway that runs from early screening and precision diagnostics to advanced treatment and rehabilitation.
Two areas — start with yours
Oncology
Options you can raise with a hospital, grouped by diagnostics, targeted and immunotherapy medicines, and local treatments and advanced devices. Every item depends on the hospital's assessment and quote — no bundled packages, no headline totals.
Type 2 diabetes management
We start with the framework that matters: specialist assessment, in-depth screening, continuous glucose monitoring, complication management and long-term follow-up. Stem-cell programmes are covered separately on the diabetes page and are pending written confirmation from our partner hospitals; we publish no prices for them, and course length and scheduling follow the hospital’s written arrangement.
Four steps, that's all
For your first message, please don't send passport scans, payment details or complete medical records — just tell us what you'd like to arrange.
Tell us what you need
A free conversation — assessment, an appointment, or a complex case — in the language you're most comfortable with.
Agree what help you need
Together, we clarify what needs coordinating, which records to prepare, and which decisions only a hospital can make.
Confirm scope and fees in writing
The scope, our fee and the timeline are confirmed in writing before anything starts — no verbal promises.
The hospital handles the medicine
Case acceptance, treatment plans, quotes and treatment itself are decided and delivered by the hospital and its doctors. We handle the coordination in between.
Clear boundaries, up front
- Our coordination fee and the hospital's medical fees are separate. The hospital quotes and charges its own fees; our coordination fee is set out separately in the written confirmation.
- We are not a hospital. We don't diagnose or recommend treatment, and we can't guarantee that any hospital will accept a case or that any treatment will work.
- We don't guess prices. Nothing listed on this site carries a price; your costs depend on the hospital's assessment of your case and its quote.
- We do not arrange visas or issue invitation letters; only the treating hospital can issue an invitation letter. See the Process & Visa page for how visas work Our service scope — To be confirmed
Client stories: real cases, published with consent
This section is empty — on purpose
Every patient story published here will be a real one, shared with the patient's written consent. Authorised cases will appear after the official launch. Until then, we won't invent names, reviews, ratings or figures.
Cases will be published once authorised